Symbol | Exchange | Currency |
|---|
Ardelyx, Inc. (Nasdaq: NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet...
WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize...
Ardelyx, Inc. (Nasdaq: NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet...
Continued successful launch of IBSRELA, with Q1 net product sales of $11.4 million XPHOZAH New Drug Application resubmitted on April 17, 2023 Company ends Q1 with over $130 million...
WALTHAM, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize...
WALTHAM, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize...
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. The Company's product pipeline includes IBSRELA (tenapanor), XPHOZAH, RDX013 Program, and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control of hyperphosphatemia or serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). XPHOZAH is a medicine for the control of serum phosphorus in adult patients with CKD on dialysis. RDX013 Program is a small molecule potassium secretagogue program for the treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 4.23 | 4.25 | 4.15 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 15.40 | 15.40 | 14.25 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 3.69 | 3.69 | 3.69 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 6.80 | 7.00 | 7.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.43 | 0.43 | 0.43 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 4.08 | 4.02 | 4.02 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 10.00 | 10.00 | 9.85 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 13.85 | 13.85 | 13.55 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 1.40 | 1.40 | 1.40 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 40.95 | 40.95 | 40.95 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 3.06 | 3.06 | 3.06 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 38.60 | 38.50 | 38.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 5.66 | 5.67 | 5.53 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 250.00 | 250.00 | 250.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 1,200.00 | 1,200.00 | 1,200.00 | 0.00 | 0.00% | 0.00 | Lagos |